Inhibition of ADORA3 promotes microglial phagocytosis and alleviates chronic ischemic white matter injury.
Yuhao XuLimoran TangChao ZhouLiang SunYujie HuZhi ZhangShengnan XiaXinyu BaoHaiyan YangYun XuPublished in: CNS neuroscience & therapeutics (2024)
ADORA3 antagonist alleviates chronic ischemic WMI by modulating myelin clearance of microglia, which may be a potential therapeutic target for the treatment of VaD.